REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Supra - Biotec S.A.S. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Supra - Biotec S.A.S. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Supra - Biotec S.A.S. is based in Ecuador, with the head office in Quito. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on April 12, 2021. 14 (2023) employees currently work for Supra - Biotec S.A.S.. Its’ total assets recorded a growth of 80%.

Headquarters
Naciones Unidas E9-74, Edificio Ordonez Bldg. , Floor 3
Quito; Pichincha;

Contact Details: Purchase the Supra - Biotec S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Supra - Biotec S.A.S. report to view the information.
Outstanding Shares:
Purchase the Supra - Biotec S.A.S. report to view the information.
Registered Capital:
Purchase the Supra - Biotec S.A.S. report to view the information.
Incorporation Date:
April 12, 2021
Key Executives
Purchase this report to view the information.
Administrative Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Supra - Biotec S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total assets
80%▲
Total equity
80%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo